UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000023721
Receipt number R000027325
Scientific Title Repetitive Transcranial Magnetic Stimulationfor 2010 criteria diagnosed Fibromyalgia with a comorbidity of depression: Evidence from a pilot Randomized Sham-Controlled Study
Date of disclosure of the study information 2016/08/22
Last modified on 2017/05/17 22:14:28

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Repetitive Transcranial Magnetic Stimulationfor 2010 criteria diagnosed Fibromyalgia with a comorbidity of depression: Evidence from a pilot Randomized Sham-Controlled Study

Acronym

the analgesic effect of rTMS in patients with modified 2010 ACR and comorbided with major depressive disorder

Scientific Title

Repetitive Transcranial Magnetic Stimulationfor 2010 criteria diagnosed Fibromyalgia with a comorbidity of depression: Evidence from a pilot Randomized Sham-Controlled Study

Scientific Title:Acronym

the analgesic effect of rTMS in patients with modified 2010 ACR and comorbided with major depressive disorder

Region

Asia(except Japan)


Condition

Condition

A treatment option for Medication-resistant fibromyalgia

Classification by specialty

Medicine in general Psychiatry Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We will investigate and compare the efficacy between left sided prefrontal 10 Hz rTMS and sham stimulation to treat fibromyalgia in patients with major depressive disorder.

Basic objectives2

Others

Basic objectives -Others

We further evaluate the serum inflammatory factors or Brain activity by FDG-PET or cognitive function to find predicting factors of the analgesic effect of rTMS.

Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Phase III


Assessment

Primary outcomes

the changing of VAS-pain (week-2 vs. baseline) in response to the 2-week prefrontalrTMS

Key secondary outcomes

FDG-PET; CANTAB for working memory, go/no-goand MSCEIT; serum IL-2, IL-6, TNF-alpha, insulin, CRP; Young mania Rating scale; Clinical Global Index; Hamilton Depression Rating Scales-17 item; Life stress scale; Pittsburgh Sleep Quality Index;12-Item Short Form Health Survey; short-form McGill Pain Questionnaire; Patient Health Questionnaire


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Cluster

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

YES

Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Left DLPFC 10Hz rTMS group (1 session/day, 5 days/week,2weeks); 100% motor threshold,1600 pulses once

Interventions/Control_2

Sham group(1 session/day, 5 days/week,2weeks)
using a sham coil.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

70 years-old >=

Gender

Male and Female

Key inclusion criteria

adult patients with a modified ACR 2010 diagnosis of fibromyalgia and major depressive disorder

Key exclusion criteria

Patients were excluded if they had a lifetime psychiatric history of psychotic disorders, bipolar I or II disorder, substance abuse or dependence, personality disorders (based on DSM-IV criteria) or a lifetime medical history of major systemic illness, neurological disorders (e.g. stroke, post-brain surgery, epilepsy, traumatic brain injury), or cardiac pacemakers, brain implants or neurostimulators; or if they were pregnant.

Target sample size

40


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Cheng-Ta Li

Organization

Taipei Veterans General Hospital, Taiwan

Division name

Psychiatry

Zip code


Address

No.201, Sec. 2, Shih-Pai Road, Beitou district, Taipei, Taiwan

TEL

+88628757027

Email

on5083@msn.com


Public contact

Name of contact person

1st name
Middle name
Last name Cheng-Ta Li

Organization

Taipei Veterans General Hospital, Taiwan

Division name

Psychiatry

Zip code


Address

No.201, Sec. 2, Shih-Pai Road, Beitou district, Taipei, Taiwan

TEL

+88628757027

Homepage URL


Email

on5083@msn.com


Sponsor or person

Institute

Taipei Veterans General Hospital, Taiwan

Institute

Department

Personal name



Funding Source

Organization

Taipei Veterans General Hospital, Taiwan

Organization

Division

Category of Funding Organization

Outside Japan

Nationality of Funding Organization

Taiwan, ROC


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 08 Month 22 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2013 Year 09 Month 05 Day

Date of IRB


Anticipated trial start date

2013 Year 10 Month 11 Day

Last follow-up date

2016 Year 09 Month 10 Day

Date of closure to data entry

2016 Year 09 Month 10 Day

Date trial data considered complete

2016 Year 09 Month 10 Day

Date analysis concluded

2016 Year 09 Month 10 Day


Other

Other related information



Management information

Registered date

2016 Year 08 Month 22 Day

Last modified on

2017 Year 05 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027325


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name